A clinical trial of Glenn type 3 attenuated poliovirus vaccine

@article{Barnes1967ACT,
  title={A clinical trial of Glenn type 3 attenuated poliovirus vaccine},
  author={Joan M. Barnes and C. S. Heymann and N. S. Galbraith and G. R. O'Moore},
  journal={Archiv f{\"u}r die gesamte Virusforschung},
  year={1967},
  volume={20},
  pages={296-304}
}
A small clinical trial with the Glenn type 3 poliovirus vaccine has shown that the strain is antigenic and retains its attenuated characters on human passage at least as well as any other reported type 3 strain. The antigenicity and stability of the various type 3 vaccine strains should be compared in a larger clinical trial.